In a report by WHO (2014), it was stated that antimicrobial resistance is an arising challenge
that needs to be resolved. This resistance is a critical issue in terms of disease or infection …

The evolution of pathogenic bacteria has allowed many microbes to develop resistance
mechanisms against conventional antibiotics, leading to the search for new therapeutic …

Antimicrobial peptides (AMPs) are short peptidic molecules produced by most living
creatures. They help unicellular organisms to successfully compete for nutrients with other …

Antimicrobial peptides (AMPs) are an important component of the natural defences of most
living organisms against invading pathogens. These are relatively small (< 10kDa), cationic …

Antimicrobial drugs resistant microbes have been observed worldwide and therefore
alternative development of antimicrobial peptides has gained interest in human healthcare …

The severe infection is becoming a significant health problem which threaten the lives of
patients and the safety and economy of society. In the way of finding new strategy …

Antimicrobial peptides are diverse group of biologically active molecules with
multidimensional properties. In recent past, a wide variety of AMPs with diverse structures …

Antimicrobial peptides (AMPs) are compounds, which have inhibitory activity against
microorganisms. In the last decades, AMPs have become powerful alternative agents that …

For over fifty years, people have used antibiotics to treat illnesses caused by pathogens.
However, the excessive and inappropriate use of these antibiotics in clinical treatment of …

More than 3000 antimicrobial peptides (AMPs) have been discovered, seven of which have
been approved by the US Food and Drug Administration (FDA). Now commercialized, these …